Pute Medical's Application for Delisting Accepted, Stock Trading Remains Suspended

*Source: Pute Medical's "Announcement on Receipt of Notice of Acceptance for Delisting and Stock Trading Suspension Progress"

DentalGoodNews | Recently, Zhejiang Pute Medical Device Co., Ltd. (hereinafter referred to as "Pute Medical") released the "Announcement on Receipt of Notice of Acceptance for Delisting and Stock Trading Suspension Progress." The announcement stated that the company has received the Notice of Acceptance for Delisting (No.: ZZGP2026010025) issued by the National Equities Exchange and Quotations (NEEQ) system, and its application to terminate stock listing on the National Equities Exchange and Quotations has been officially accepted. Given that the matter is still under review, the company's stock trading will remain suspended.

According to the announcement, Pute Medical, based on current industry development trends and its own business situation, intends to further improve decision-making efficiency, reduce operating costs, and integrate internal and external resources to focus on its core business development through delisting. The company held the fourth meeting of its second board of directors on January 13, 2026, and the first extraordinary shareholders' meeting of 2026 on January 28, 2026, both of which approved the delisting-related proposals. Subsequently, on January 30, the company submitted the delisting application materials to the NEEQ and received acceptance approval.

The company stated that it will strictly fulfill its information disclosure obligations in accordance with relevant laws, regulations, and business rules, and timely disclose the progress of the delisting matter to the market.

*Source: Pute Medical's 2025 Semi-Annual Report

From an operational perspective, Pute Medical's fundamentals remain stable. Its financial data shows that the company achieved operating revenue of 196 million yuan in 2024, with net profit attributable to listed company shareholders of 73 million yuan. In the first half of 2025, it achieved operating revenue of 83 million yuan; net profit attributable to shareholders was 30 million yuan, a year-on-year increase of 11.85%; and the gross margin remained at a relatively high level of 77.69%.

Public information shows that Pute Medical was established in 2007 and is a high-tech enterprise specializing in the research, development, production, and sales of orthodontic materials. As of the end of June 2025, the company had accumulated 115 patents, including 8 invention patents. In terms of equity structure, the company currently has 7 shareholders, with the top three shareholders collectively holding approximately 64% of the shares.